» Articles » PMID: 26236608

A Case of Pulmonary Lymphangioleiomyomatosis Complicated with Uterine and Retroperitoneal Tumors

Overview
Date 2015 Aug 4
PMID 26236608
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

A 39-year-old female experienced dyspnea on exertion for eight months. Chest CT demonstrated findings of Lymphangioleiomyomatosis (LAM), including diffuse thin-walled cystic lesions. A surgical lung biopsy revealed human melanoma black-45-positive cell infiltration and aggregation, resulting in a diagnosis of sporadic LAM without tuberous sclerosis complex. Pelvic MRI showed two large tumors, one of which was in the myometrium and the other was in the retroperitoneal space. Because we were not able to exclude the presence of malignant tumors using MR imaging, the tumors were surgically resected. The histopathology demonstrated the resected tumors to be composed of LAM cells. The patient's symptoms worsened, and sirolimus was administered, which improved the dyspnea and pulmonary function. The adverse effect was mild liver damage. Following the initiation of treatment with sirolimus, transient elevation of the serum KL-6 level was detected without interstitial pneumonia. This LAM case complicated with large uterine and retroperitoneal tumors was successfully treated with surgical resection and sirolimus.

Citing Articles

Low-dose sirolimus in retroperitoneal lymphangioleiomyomas.

Ussavarungsi K, Laroia A, Burger C Lung India. 2019; 36(4):349-352.

PMID: 31290423 PMC: 6625232. DOI: 10.4103/lungindia.lungindia_433_18.


Extrapulmonary uterine lymphangioleiomyomatosis (LAM) and dysfunctional uterine bleeding: the first presentation of LAM in a tuberous sclerosis complex patient.

Grant L, Chipwete S, Soo Hoo S, Bhatnagar A BMJ Case Rep. 2019; 12(2).

PMID: 30804158 PMC: 6388898. DOI: 10.1136/bcr-2018-226358.


Pulmonary lymphangioleiomyomatosis in a 46-year-old female: A case report and review of the literature.

Zhou B, Guo Q, Zhou H, Xie W, Xue T, Li M Biomed Rep. 2016; 4(6):719-722.

PMID: 27284412 PMC: 4887979. DOI: 10.3892/br.2016.652.

References
1.
Matsui K, Beasley M, Nelson W, Barnes P, Bechtle J, Falk R . Prognostic significance of pulmonary lymphangioleiomyomatosis histologic score. Am J Surg Pathol. 2001; 25(4):479-84. DOI: 10.1097/00000478-200104000-00007. View

2.
Hayashi T, Kumasaka T, Mitani K, Terao Y, Watanabe M, Oide T . Prevalence of uterine and adnexal involvement in pulmonary lymphangioleiomyomatosis: a clinicopathologic study of 10 patients. Am J Surg Pathol. 2011; 35(12):1776-85. DOI: 10.1097/PAS.0b013e318235edbd. View

3.
CARRINGTON C, CUGELL D, GAENSLER E, Marks A, Redding R, SCHAAF J . Lymphangioleiomyomatosis. Physiologic-pathologic-radiologic correlations. Am Rev Respir Dis. 1977; 116(6):977-95. DOI: 10.1164/arrd.1977.116.6.977. View

4.
Carsillo T, Astrinidis A, Henske E . Mutations in the tuberous sclerosis complex gene TSC2 are a cause of sporadic pulmonary lymphangioleiomyomatosis. Proc Natl Acad Sci U S A. 2000; 97(11):6085-90. PMC: 18562. DOI: 10.1073/pnas.97.11.6085. View

5.
Corrin B, LIEBOW A, Friedman P . Pulmonary lymphangiomyomatosis. A review. Am J Pathol. 1975; 79(2):348-82. PMC: 1912658. View